Undetectable AMH at 3days of age: A clue to bilateral anorchia

Clinical Biochemistry

Volumn 43, Issue 16-17, 2010, Pages 1373-1374

  Stoppa Vaucher, Sophie ^a,b   Djemli, Anissa ^a   Van Vliet, Guy ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

AMH; Anorchia; FSH; Vanishing testis syndrome

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ANORCHIA; ANXIETY; ARTICLE; BLOOD VESSEL OCCLUSION; CASE REPORT; CRYPTORCHISM; HUMAN; MALE; MICROPENIS; MORPHOGENESIS; NEWBORN; PRIORITY JOURNAL; SERTOLI CELL; TESTIS TORSION; ULTRASOUND; BLOOD; FEMALE; PREGNANCY;

ANTI-MULLERIAN HORMONE; CRYPTORCHIDISM; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY;

EID: 77957359103     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.08.022     Document Type: Article

References (12)

1. Levitt S.B., Kogan S.J., Engel R.M., Weiss R.M., Martin D.C., Ehrlich R.M. The impalpable testis: a rational approach to management. J Urol 1978, 120:515-520.
2. Aynsley-Green A., Zachmann M., Illig R., Rampini S., Prader A. Congenital bilateral anorchia in childhood: a clinical, endocrine and therapeutic evaluation of twenty-one cases. Clin Endocrinol 1976, 5:381-391. (Oxf).
3. Philibert P., Zenaty D., Lin L., Soskin S., Audran F., Leger J., et al. Mutational analysis of steroidogenic factor 1 (nr5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod 2007, 22:3255-3261.
4. McEachern R., Houle A.M., Garel L., Van Vliet G. Lost and found testes: the importance of the hcg stimulation test and other testicular markers to confirm a surgical declaration of anorchia. Horm Res 2004, 62:124-128.
5. Jarow J.P., Berkovitz G.D., Migeon C.J., Gearhart J.P., Walsh P.C. Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism. J Urol 1986, 136:277-279.
6. Lustig R.H., Conte F.A., Kogan B.A., Grumbach M.M. Ontogeny of gonadotropin secretion in congenital anorchism: sexual dimorphism versus syndrome of gonadal dysgenesis and diagnostic considerations. J Urol 1987, 138:587-591.
7. Bergada I., Milani C., Bedecarras P., Andreone L., Ropelato M.G., Gottlieb S., et al. Time course of the serum gonadotropin surge, inhibins, and anti-mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006, 91:4092-4098.
8. Grinspon R.P., Rey R.A. Anti-mullerian hormone and sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr 2010, 73:81-92.
9. Guibourdenche J., Lucidarme N., Chevenne D., Rigal O., Nicolas M., Luton D., et al. Anti-mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 2003, 211:55-63.
10. Lee M.M., Donahoe P.K., Silverman B.L., Hasegawa T., Hasegawa Y., Gustafson M.L., et al. Measurements of serum mullerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 1997, 336:1480-1486.
11. Misra M., MacLaughlin D.T., Donahoe P.K., Lee M.M. Measurement of mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab 2002, 87:3598-3602.
12. Grumbach M.M. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 2005, 90:3122-3127.